Welcome to the Editorial Board, Dr. Miller!
Brian Miller joins the Editorial Board of Psychiatric Times.
The Goldwater Rule Is Still Relevant
COUTERPOINT: A small number of psychiatrists have been critical of our profession’s restraint regarding public comments by psychiatrists about the mental health of the 45th President.
Dealing With American Psychiatry’s Gag Rule
POINT: After 41 years of membership, a psychiatrist resigns from the APA after it holds its ground on the Goldwater Rule.
Restless Legs Syndrome: Clinical Implications for Psychiatrists
While patients with restless legs syndrome may be successfully treated with a number of medications, comorbid psychiatric conditions present a unique challenge because many commonly prescribed psychiatric medications may worsen RLS symptoms.
6 Ways to Reduce No-Shows (and Save Lives)
Not just a nuisance, no-shows are an opportunity to turn things around for patients with bipolar disorder, whose treatment adherence hovers around 60%.
Culture, Diversity, and the Therapeutic Alliance: How Can Psychiatrists Contribute to the Discussion?
We psychiatrists can't solve the world's political problems, but we can help those who are affected by them. Suggestions here.
Mini Quiz: Micronutrients and Depression
Micronutrient deficiencies can bring about a range of mental health complications. Take the quiz and learn more.
CrowdStudying Ourselves: Approaches to Bipolar Disorders, Part 2
A window into what your colleagues actually think and do.
Neuroscience Research for Psychiatry: The Brain and Behavior Link
Interaction between the brain and behavior implies that comprehensive progress cannot be made to relieve the suffering of patients without systematically addressing the brain basis of such conditions.
Weighing the Benefits of Genetic Information in Clinical Psychiatry
Have you considered using pharmacogenomic testing in your practice?
By clicking Accept, you agree to become a member of the UBM Medica Community.